Skip to main content
OpenTrials
Completed

NCT Number: NCT00809666

Measuring Blood Pressure in Pregnancy Using Mercury and Automated Device

The aim of the PRAM study was to determine whether women diagnosed with hypertension in pregnancy, using the traditional mercury device, have the same pregnancy outcomes when blood pressure is measured by either an automated device or a mercury device throughout the pregnancy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

St George Hospital

Sydney, New South Wales, 2217, Australia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • women with a diagnosis of hypertension in pregnancy

Exclusion criteria

  • non-pregnant and normotensive pregnancy women

Treatment and study plan

Automated blood pressure recording device Omron HEM 705CP

Device

All subsequent blood pressure recordings done using the automated device

Primary outcomes

  1. The primary maternal outcome measure was the number of women having any episode of severe hypertension (BP ³ 170/110mmHg).

Secondary outcomes

  1. Secondary end points included gestation at birth, caesarean section and induction of labour rates.

Sponsors and collaborators

Lead sponsor

St George Hospital, Australia

Other

Registry information

Official study title

A Prospective Randomised Study of Automated Versus Mercury Blood Pressure Recordings in Pregnancy

Acronym: PRAM

Important dates

Study start
2000
Primary completion
2006
Study completion
2006
First posted
Dec 17, 2008
Registry last updated
Dec 17, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.